These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6482342)

  • 1. [Thromboembolic complications of bioprosthesis of the mitral valve of the heart].
    Tsukerman GI; Barbarash LS; Bykova VA; Fursov BA; Kokorin SG
    Klin Med (Mosk); 1984 Jul; 62(7):31-6. PubMed ID: 6482342
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitral valve replacement and thromboembolic risk.
    Benussi S; Verzini A; Alfieri O
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S81-3. PubMed ID: 15225011
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of thrombosis and thromboembolism after mitral valve bioprosthesis].
    Malinovskiĭ NN; Konstantinov BA; Cherepenin LP; Dzemeshkevich SL; Ivanov AS
    Khirurgiia (Mosk); 1982 Nov; (11):64-8. PubMed ID: 7176405
    [No Abstract]   [Full Text] [Related]  

  • 5. [Haemorrhagic and thrombo-embolic complications in patients with prosthetic valves--the under-appreciated problem with no safe solutions].
    Trzeciak P; Poloński L; Zembala M
    Kardiol Pol; 2006 Sep; 64(9):1038-42. PubMed ID: 17054041
    [No Abstract]   [Full Text] [Related]  

  • 6. [Late thromboembolic complications after mitral valve replacement].
    Slimane ML
    Tunis Med; 1985 Nov; 63(11):581-8. PubMed ID: 3835733
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative evaluation of mitral valve repair and replacement with Starr, Björk, and porcine valve prostheses.
    Perier P; Deloche A; Chauvaud S; Fabiani JN; Rossant P; Bessou JP; Relland J; Bourezak H; Gomez F; Blondeau P
    Circulation; 1984 Sep; 70(3 Pt 2):I187-92. PubMed ID: 6744563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valvular substitution using a dura mater bioprosthesis. Interim results].
    Morillo F; Senador G; Paravisini J
    Rev Esp Cardiol; 1982; 35(4):347-50. PubMed ID: 7178620
    [No Abstract]   [Full Text] [Related]  

  • 9. Heart valve replacement.
    Mearns AJ
    Practitioner; 1982 Mar; 226(1365):443-4, 447-8. PubMed ID: 7045844
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral anticoagulation in patients with mechanical valve prostheses: evolving protocols with new generation devices.
    Cotrufo M; De Feo M; De Santo LS; Della Corte A; Scardone M; Costanza S
    Ital Heart J; 2005 May; 6(5):401-4. PubMed ID: 15934413
    [No Abstract]   [Full Text] [Related]  

  • 11. [Valvular bioprostheses and anticoagulation].
    Chambaz IC; Nendaz M
    Rev Med Suisse; 2008 Oct; 4(175):2198-202. PubMed ID: 19024573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with porcine cardiac valve prostheses.
    Janusz MT; Jamieson WR; Allen P; Gerein AN; Miyagishima RT; Burr LH; Tutassaura H; Munro AI; Tyers GF
    Can J Surg; 1983 Mar; 26(2):160-2. PubMed ID: 6825007
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioprostheses: thromboembolic events in prosthetic valves. Working Group of the European Society of Cardiology on the Evaluation of Prosthetic Valves. 15-16 December, 1983, Paris, France. Abstracts.
    Eur Heart J; 1983 Dec; 4 Suppl I():1-32. PubMed ID: 6667702
    [No Abstract]   [Full Text] [Related]  

  • 14. Thromboembolic risk and durability of the Hancock bioprosthetic cardiac valve.
    Oyer PE; Stinson EB; Miller DC; Jamieson SW; Mitchell RS; Shumway NE
    Eur Heart J; 1984 Oct; 5 Suppl D():81-5. PubMed ID: 6519106
    [No Abstract]   [Full Text] [Related]  

  • 15. [Echocardiography quantification of the reduction of the outlet tract of the left ventricle caused by biological prostheses in the mitral position].
    Huerta D; Ojeda JL; Verdín R; López Reyes J; Paz RM; Friedland C; Guadalajara JF
    Arch Inst Cardiol Mex; 1982; 52(6):495-500. PubMed ID: 7159131
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathological substrates of thrombus formation after heart valve replacement with the Hancock bioprosthesis.
    Thiene G; Bortolotti U; Panizzon G; Milano A; Gallucci V
    J Thorac Cardiovasc Surg; 1980 Sep; 80(3):414-23. PubMed ID: 7412345
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors affecting performance and thromboembolism after porcine xenograft cardiac valve replacement.
    Geha AS; Hammond GL; Laks H; Stansel HC; Glenn WW
    J Thorac Cardiovasc Surg; 1982 Mar; 83(3):377-84. PubMed ID: 7062749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late results of heart valve replacement with the Hancock II bioprosthesis.
    David TE; Ivanov J; Armstrong S; Feindel CM; Cohen G
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):268-77. PubMed ID: 11174732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications with glutaraldehyde-preseved bioprostheses.
    Wright JS; Newman DC
    Med J Aust; 1980 May; 1(11):542-3. PubMed ID: 7393038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thromboembolic complications following mitral prosthesis implantation].
    Gawdziński M
    Pol Tyg Lek; 1977 Jan; 32(2):49-52. PubMed ID: 834633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.